Search

Your search keyword '"GUITART, JOAN"' showing total 1,219 results
Start Over Author "GUITART, JOAN"
1,219 results on '"GUITART, JOAN"'

2. Approach to Mycosis Fungoides in children: Consensus-based recommendations

Author

Zvulunov, Alex, Neale, Holly, Stern, Jonah, Santaguida, Pasqualina, Stein, Amy Buros, Koh, Mark, Eichenfield, Lawrence F., Guitart, Joan, Goebeler, Matthias, Scarisbrick, Julia, Willemze, Rein, Coughlin, Carrie C., George, Renu, Brazzelli, Valeria, Marschalkó, Márta, Belousova, Irena, Querfeld, Christiane, Bagot, Martine, Szepietowski, Jacek C., Papadavid, Evangelina, Quaglino, Pietro, Hoeger, Peter, Ortiz-Romero, Pablo L., Nikolaou, Vasiliki, Dummer, Reinhard, Aung, Phyu P., Lawley, Leslie, Morel, Kimberly D., Ngan, Bo, Wain, Mary, Gameiro, Ana, Lacy-Niebla, Rosa María, and Pope, Elena

Published
2024
Full Text
View/download PDF

4. ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary Syndrome

Author

Goyal, Amrita, O'Leary, Daniel, Dabaja, Bouthaina, Weng, Wen-Kai, Zain, Jasmine, Cutler, Corey, Guitart, Joan, Kim, Youn H., Geskin, Larisa J., Hoppe, Richard T., Wilson, Lynn D., Beaven, Anne W., Horwitz, Steve, Allen, Pamela B., Barta, Stefan K., Bohjanen, Kimberly, Brammer, Jonathan E., Carter, Joi B., Comfere, Nneka, DeSimone, Jennifer A., Dusenbery, Kathryn, Duvic, Madeleine, Huen, Auris, Jagadeesh, Deepa, Kelsey, Chris R., Khodadoust, Michael S., Lechowicz, Mary Jo, Mehta-Shah, Neha, Moskowitz, Alison J., Olsen, Elise A., Poh, Christina, Pro, Barbara, Querfeld, Christiane, Sauter, Craig, Sokol, Lubomir, Sokumbi, Olayemi, Wilcox, Ryan A., Zic, John A., Hamadani, Mehdi, and Foss, Francine

Published
2024
Full Text
View/download PDF

6. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Author

Alaggio, Rita, Amador, Catalina, Anagnostopoulos, Ioannis, Attygalle, Ayoma D, Araujo, Iguaracyra Barreto de Oliveira, Berti, Emilio, Bhagat, Govind, Borges, Anita Maria, Boyer, Daniel, Calaminici, Mariarita, Chadburn, Amy, Chan, John KC, Cheuk, Wah, Chng, Wee-Joo, Choi, John K, Chuang, Shih-Sung, Coupland, Sarah E, Czader, Magdalena, Dave, Sandeep S, de Jong, Daphne, Du, Ming-Qing, Elenitoba-Johnson, Kojo S, Ferry, Judith, Geyer, Julia, Gratzinger, Dita, Guitart, Joan, Gujral, Sumeet, Harris, Marian, Harrison, Christine J, Hartmann, Sylvia, Hochhaus, Andreas, Jansen, Patty M, Karube, Kennosuke, Kempf, Werner, Khoury, Joseph, Kimura, Hiroshi, Klapper, Wolfram, Kovach, Alexandra E, Kumar, Shaji, Lazar, Alexander J, Lazzi, Stefano, Leoncini, Lorenzo, Leung, Nelson, Leventaki, Vasiliki, Li, Xiao-Qiu, Lim, Megan S, Liu, Wei-Ping, Louissaint, Abner, Marcogliese, Andrea, Medeiros, L Jeffrey, Michal, Michael, Miranda, Roberto N, Mitteldorf, Christina, Montes-Moreno, Santiago, Morice, William, Nardi, Valentina, Naresh, Kikkeri N, Natkunam, Yasodha, Ng, Siok-Bian, Oschlies, Ilske, Ott, German, Parrens, Marie, Pulitzer, Melissa, Rajkumar, S Vincent, Rawstron, Andrew C, Rech, Karen, Rosenwald, Andreas, Said, Jonathan, Sarkozy, Clémentine, Sayed, Shahin, Saygin, Caner, Schuh, Anna, Sewell, William, Siebert, Reiner, Sohani, Aliyah R, Tooze, Reuben, Traverse-Glehen, Alexandra, Vega, Francisco, Vergier, Beatrice, Wechalekar, Ashutosh D, Wood, Brent, Xerri, Luc, and Xiao, Wenbin

Subjects
Cancer, Hematologic Neoplasms, Humans, Lymphoma, World Health Organization, Clinical Sciences, Oncology and Carcinogenesis, Immunology
Abstract

We herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.

Published
2022

8. PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma

Author

Wartewig, Tim, Daniels, Jay, Schulz, Miriam, Hameister, Erik, Joshi, Abhinav, Park, Joonhee, Morrish, Emma, Venkatasubramani, Anuroop V., Cernilogar, Filippo M., van Heijster, Frits H. A., Hundshammer, Christian, Schneider, Heike, Konstantinidis, Filippos, Gabler, Judith V., Klement, Christine, Kurniawan, Henry, Law, Calvin, Lee, Yujin, Choi, Sara, Guitart, Joan, Forne, Ignasi, Giustinani, Jérôme, Müschen, Markus, Jain, Salvia, Weinstock, David M., Rad, Roland, Ortonne, Nicolas, Schilling, Franz, Schotta, Gunnar, Imhof, Axel, Brenner, Dirk, Choi, Jaehyuk, and Ruland, Jürgen

Published
2023
Full Text
View/download PDF

9. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

Author

Alaggio, Rita, Amador, Catalina, Anagnostopoulos, Ioannis, Attygalle, Ayoma D., de Oliveira Araujo, Iguaracyra Barreto, Berti, Emilio, Bhagat, Govind, Borges, Anita Maria, Boyer, Daniel, Calaminici, Mariarita, Chadburn, Amy, Chan, John K. C., Cheuk, Wah, Chng, Wee-Joo, Choi, John K., Chuang, Shih-Sung, Coupland, Sarah E., Czader, Magdalena, Dave, Sandeep S., de Jong, Daphne, Di Napoli, Arianna, Du, Ming-Qing, Elenitoba-Johnson, Kojo S., Ferry, Judith, Geyer, Julia, Gratzinger, Dita, Guitart, Joan, Gujral, Sumeet, Harris, Marian, Harrison, Christine J., Hartmann, Sylvia, Hochhaus, Andreas, Jansen, Patty M., Karube, Kennosuke, Kempf, Werner, Khoury, Joseph, Kimura, Hiroshi, Klapper, Wolfram, Kovach, Alexandra E., Kumar, Shaji, Lazar, Alexander J., Lazzi, Stefano, Leoncini, Lorenzo, Leung, Nelson, Leventaki, Vasiliki, Li, Xiao-Qiu, Lim, Megan S., Liu, Wei-Ping, Louissaint, Jr, Abner, Marcogliese, Andrea, Medeiros, L. Jeffrey, Michal, Michael, Miranda, Roberto N., Mitteldorf, Christina, Montes-Moreno, Santiago, Morice, William, Nardi, Valentina, Naresh, Kikkeri N., Natkunam, Yasodha, Ng, Siok-Bian, Oschlies, Ilske, Ott, German, Parrens, Marie, Pulitzer, Melissa, Rajkumar, S. Vincent, Rawstron, Andrew C., Rech, Karen, Rosenwald, Andreas, Said, Jonathan, Sarkozy, Clémentine, Sayed, Shahin, Saygin, Caner, Schuh, Anna, Sewell, William, Siebert, Reiner, Sohani, Aliyah R., Suzuki, Ritsuro, Tooze, Reuben, Traverse-Glehen, Alexandra, Vega, Francisco, Vergier, Beatrice, Wechalekar, Ashutosh D., Wood, Brent, Xerri, Luc, and Xiao, Wenbin

Published
2023
Full Text
View/download PDF

10. Lymphomatoid Papulosis With T-cell Receptor–Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis

Author

Mark, Erica, Kempf, Werner, Guitart, Joan, Pulitzer, Melissa, Mitteldorf, Christina, Hristov, Alexandra, Torres-Cabala, Carlos, Marchi, Enrica, Cropley, Thomas, Rodriguez Pinilla, Socorro Maria, Griffin, Teresa, Fernandez, Rony, Pileri, Stefano, Pileri, Alessandro, Tabanelli, Valentina, Borretta, Lisa, Subtil, Antonio, Plaza, Jose Antonio, Piris, Jose A. Miguel Angel, Feldman, Andrew L., Cerroni, Lorenzo, and Gru, Alejandro A.

Published
2024
Full Text
View/download PDF

18. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Author

Olsen, Elise A., Whittaker, Sean, Willemze, Rein, Pinter-Brown, Lauren, Foss, Francine, Geskin, Larisa, Schwartz, Lawrence, Horwitz, Steven, Guitart, Joan, Zic, John, Kim, Youn H., Wood, Gary S., Duvic, Madeleine, Ai, Wei, Girardi, Michael, Gru, Alejandro, Guenova, Emmanuella, Hodak, Emmilia, Hoppe, Richard, Kempf, Werner, Kim, Ellen, Lechowicz, Mary Jo, Ortiz-Romero, Pablo, Papadavid, Evangelia, Quaglino, Pietro, Pittelkow, Mark, Prince, H. Miles, Sanches, Jose Antonio, Sugaya, Makoto, Vermeer, Maarten, Zain, Jasmine, Knobler, Robert, Stadler, Rudolf, Bagot, Martine, and Scarisbrick, Julia

Published
2022
Full Text
View/download PDF

19. Ionizing radiation improves skin bacterial dysbiosis in cutaneous T-cell lymphoma.

Author

Chrisman, Lauren P., Pang, Yanzhen, Hooper, Madeline J., Rajeev-Kumar, Greeshma, Nguyen, William Q., Green, Stefan J., Seed, Patrick C., Liang, Hua, Mittal, Bharat B., Hasan, Yasmin, Guitart, Joan, Weichselbaum, Ralph R., Burns, Michael B., and Zhou, Xiaolong A.

Abstract

Introduction: Cutaneous T-cell lymphoma (CTCL) is closely associated with the host microbiome. While recent evidence suggests that shifts in specific bacterial taxa are associated with response to UV-B, a form of non-ionizing radiation, the impact of ionizing radiation (IR) has not been investigated. Methods: 16S rRNA and tuf gene amplicon sequencing were performed on DNA extracted from swabs of lesional/non-lesional skin of 12 CTCL patients before/after TSEBT or local IR and from 25 matched healthy controls (HC). Microbial diversity and taxonomic profiles were analyzed. Results: Radiation exposure increased CTCL skin α-diversity to levels approximating HC. TSEBT appeared to carry the greatest effect compared to local IR. Both α and β-diversity differed significantly post versus pre-IR for TSEBT, but not for local IR. IR was associated with decreases in known pathogenic bacteria such as Streptococcus and S. aureus and increases in healthy commensal bacteria such as Anaerococcus, Bifidobacterium and commensal staphylococci including S. pettenkoferi. Substantially more taxa shifts were seen with TSEBT versus local IR. Discussion: IR not only eliminates CTCL lesions via induction of apoptosis, but also facilitates skin barrier restoration and recolonization of bacterial taxa associated with a healthy skin microbiome. Local IR does not have as strong an effect on the skin microbiome as TSEBT. As skin microbiota act as immunomodulators with local and potentially systemic influence, TSEBT may also improve CTCL lesions via global effects on the skin microbiome. Future larger-scale studies are required to fully elucidate the relationship between cutaneous microbes and IR treatment in CTCL. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

20. Development and psychometric properties of the Functional Assessment of Cancer Therapy–Cutaneous T-Cell Lymphoma (FACT-CTCL) instrument.

Author

Raymundo, Caroline, Cella, David, Wagner, Lynne I, Hippe, Daniel S, Di, Mengyang, Guitart, Joan, Rosen, Steven T, Querfeld, Christiane, and Shinohara, Michi M

Subjects
EXPLORATORY factor analysis, INTRACLASS correlation, MYCOSIS fungoides, ELECTRONIC health records, T-cell lymphoma
Abstract

Background Patients with mycosis fungoides (MF)/Sézary Syndrome (SS) can experience impacted health-related quality of life (HRQoL). Objectives To validate the CTCL-S, a novel subscale of the Functional Assessment of Cancer Therapy–General (FACT-G), in patients with MF/SS. Methods Qualitative interviews were conducted with expert clinicians and patients with MF/SS. Thematic analysis identified the most common concerns, and 19 items were selected. Patients with MF/SS were recruited from a single centre. FACT-G, CTCL-S (collectively 'FACT-CTCL'), Skindex-29 and Visual Analogue Scale–Pruritis (VAS-itch) were administered. A subset repeated FACT-CTCL and VAS-itch after ≈2 weeks. Patient demographics and clinical characteristics were obtained via review of the electronic medical records. Psychometric properties were assessed. Internal consistency was estimated using Cronbach's α. Convergent and discriminant validity were assessed by comparing CTCL-S with disease stage, age, VAS-itch, FACT-G and Skindex-29. Exploratory factor analysis (EFA) was used to preliminarily assess CTCL-S dimensionality. Test–retest repeatability was summarized using intraclass correlation coefficient (ICC), within-subject standard deviation and within-subject coefficient of variation. Results Seventy-two patients completed the initial survey, and 35 repeated the FACT-CTCL and VAS-itch after ≈2 weeks. Two-thirds were men; most were White (78%). The majority (85%) had MF, 15% had SS and 75% early (stage IA–IIA) and 25% advanced (≥ stage IIB) disease. Preliminary EFA found a single predominant factor, supporting a hypothesis of unidimensionality of the CTCL-S. Internal consistency of the CTCL-S was high, with α = 0.95 [95% confidence interval (CI) 0.93–0.96]. There was no significant change in CTCL-S average test–retest scores [ICC 0.93 (P = 0.63)]. CTCL-S was significantly lower in advanced vs. early-stage disease [median (interquartile range) 34 (26–48) vs. 59 (44–68), P < 0.001] and strongly correlated with VAS-itch [Spearman's r (rs) –0.70, 95% CI –0.81 to –0.55], FACT-G (rs 0.77, 95% CI 0.65–0.85) and Skindex-29 (rs –0.90, 95% CI –0.94 to –0.84), supporting convergent validity. CTCL-S scores had little correlation with age (rs 0.19, 95% CI –0.05 to 0.41, P = 0.12), supporting discriminant validity. Conclusions The FACT-CTCL is a disease-specific instrument for assessing HRQoL with high reproducibility and good performance in a cohort of patients with MF/SS. [ABSTRACT FROM AUTHOR]

Published
2025
Full Text
View/download PDF

21. Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify Sézary syndrome patients with low blood burden

Author

Chrisman, Lauren P, primary, Trimark, Payton Fors, additional, Pang, Yanzhen, additional, Pease, David R., additional, Martinez Escala, Maria Estela, additional, Nguyen, William, additional, Fernandez, Rony, additional, Griffin, Teresa Lila, additional, Ayanruoh, Lindsey, additional, Hooper, Madeline J, additional, Zhou, Xiaolong Alan, additional, Fu, Lucy, additional, Wolniak, Kristy Lucile, additional, and Guitart, Joan, additional

Published
2024
Full Text
View/download PDF

23. Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity

Author

Park, Joonhee, Daniels, Jay, Wartewig, Tim, Ringbloom, Kimberly G., Martinez-Escala, Maria Estela, Choi, Sara, Thomas, Jane J., Doukas, Peter G., Yang, Jingyi, Snowden, Caroline, Law, Calvin, Lee, Yujin, Lee, Katie, Zhang, Yancong, Conran, Carly, Tegtmeyer, Kyle, Mo, Samuel H., Pease, David R., Jothishankar, Balaji, Kwok, Pui-Yan, Abdulla, Farah R., Pro, Barbara, Louissaint, Abner, Boggon, Titus J., Sosman, Jeffrey, Guitart, Joan, Rao, Deepak, Ruland, Jürgen, and Choi, Jaehyuk

Published
2021
Full Text
View/download PDF

24. Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas

Author

Guitart, Joan, Martinez-Escala, M Estela, Subtil, Antonio, Duvic, Madeleine, Pulitzer, Melissa P, Olsen, Elise A, Kim, Ellen, Rook, Alain H, Samimi, Sara S, Wood, Gary S, Girardi, Michael, Junkins-Hopkins, Jacqueline, Ivan, Doina S, Selim, M Angelica, Sable, Kimberly A, Virmani, Pooja, Pincus, Laura B, Tetzlaff, Michael T, Kim, Jinah, and Kim, Youn H

Subjects
Biomedical and Clinical Sciences, Cardiovascular Medicine and Haematology, Oncology and Carcinogenesis, Lymphatic Research, Orphan Drug, Cancer, Lymphoma, Clinical Research, Rare Diseases, Transplantation, Hematology, Adult, Aged, Aged, 80 and over, Female, Humans, Lymphoma, T-Cell, Cutaneous, Male, Middle Aged, Skin Neoplasms, T-Lymphocytes, Cytotoxic, World Health Organization, Young Adult, Medical and Health Sciences, Pathology, Clinical sciences
Abstract

Primary cutaneous CD8-positive aggressive epidermotropic T-cell lymphoma is a rare and poorly characterized variant of cutaneous lymphoma still considered a provisional entity in the latest 2016 World Health Organization Classification of Cutaneous lymphomas. We sought to better characterize and provide diagnostic and therapeutic guidance of this rare cutaneous lymphoma. Thirty-four patients with a median age of 77 years (range 19-89 years) presented primarily with extensive annular necrotic plaques or tumor lesions with frequent mucous membrane involvement. The 5-year survival was 32% with a median survival of 12 months. A subset of 17 patients had a prodrome of chronic patches prior to the development of aggressive ulcerative lesions. We identified cases with lack of CD8 or αβ T-cell receptor expression yet with similar clinical and pathological presentation. Allogeneic stem cell transplantation provided partial or complete remissions in 5/6 patients. We recommend the term primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphoma as this more broad designation better describes this clinical-pathologic presentation, which allows the inclusion of cases with CD8 negative and/or αβ/γδ T-cell receptor chain double-positive or double-negative expression. We have identified early skin signs of chronic patch/plaque lesions that are often misdiagnosed as eczema, psoriasis, or mycosis fungoides. Our experience confirms the poor prognosis of this entity and highlights the inefficacy of our standard therapies with the exception of allogeneic stem cell transplantation in selected cases.

Published
2017

25. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features

Author

Zhou, Xiaolong Alan, Yang, Jingyi, Ringbloom, Kimberly G., Martinez-Escala, Maria Estela, Stevenson, Kristen E., Wenzel, Alexander T., Fantini, Damiano, Martin, Haley K., Moy, Andrea P., Morgan, Elizabeth A., Harkins, Shannon, Paxton, Christian N., Hong, Bo, Andersen, Erica F., Guitart, Joan, Weinstock, David M., Cerroni, Lorenzo, Choi, Jaehyuk, and Louissaint, Abner, Jr

Published
2021
Full Text
View/download PDF

32. Expression of CD31/PECAM-1 (Platelet Endothelial Cell Adhesion Molecule 1) by Blastic Plasmacytoid Dendritic Cell Neoplasms

Author

Salva, Katrin A, Haemel, Anna K, Pincus, Laura B, Liu, Jing, Sundram, Uma, Guitart, Joan, Longley, B Jack, and Wood, Gary S

Subjects
Biochemistry and Cell Biology, Biomedical and Clinical Sciences, Biological Sciences, Cancer, Aged, 80 and over, Dendritic Cells, Disease Progression, Humans, Immunohistochemistry, Male, Phenotype, Platelet Endothelial Cell Adhesion Molecule-1, Skin Neoplasms, Clinical Sciences, Dermatology & Venereal Diseases, Clinical sciences
Abstract

ImportanceBlastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare malignant neoplasm with cutaneous manifestations and a rapidly progressive clinical course. The diagnosis relies on characteristic clinicopathologic and immunopathologic features. However, the overlap of immunophenotypic features with other cancers, as well as newly discovered interpersonal and intrapersonal phenotypic variations, renders the identification of BPDCN challenging. A greater understanding of the proteins expressed by BPDCN might facilitate its recognition and provide insights into its clinical behavior.ObservationsIn 7 of 9 patients at 4 tertiary care institutions, immunohistochemical analysis demonstrated strong CD31/PECAM-1 (platelet endothelial cell adhesion molecule 1) expression by neoplastic cells. Combined with similar findings observed in 1 former patient, 8 of 10 cases of BPDCN were CD31/PECAM-1 positive.Conclusions and relevanceExpression of CD31/PECAM-1 by BPDCN adds new information about the antigenic profile of this unusual neoplasm. CD31/PECAM-1 influences multiple cell functions including adhesion, apoptosis, coagulation, host response, and protein synthesis that might affect clinical features of BPDCN such as hemorrhage, aggressive tumor growth, and resistance to therapy. Therefore, the potential role of this molecule in the tumor formation and progression of BPDCN warrants additional exploration.

Published
2014

37. Reply to Wu et al's US SEER analysis of sepsis in Black patients with CTCL

Author

Hooper, Madeline J., primary, Veon, Francesca L., additional, Enriquez, Gail L., additional, Nguyen, Morgan, additional, Grimes, Cameron B., additional, LeWitt, Tessa M., additional, Pang, Yanzhen, additional, Case, Slaton, additional, Choi, Jaehyuk, additional, Guitart, Joan, additional, Burns, Michael B., additional, and Zhou, Xiaolong A., additional

Published
2023
Full Text
View/download PDF

38. Elucidating genetic factors of cutaneous T-cell lymphoma staging and disease severity through machine learning

Author

Schreidah, Celine M., primary, Reynolds, George Bingham, additional, Shen, Haoyang, additional, Fahmy, Lauren M., additional, Choi, Jaehyuk, additional, Duvic, Madeleine, additional, Gallardo, Fernando, additional, Girardi, Michael, additional, Guitart, Joan, additional, Kim, Youn H., additional, Khodadoust, Michael, additional, Najidh, Safa, additional, Ni, Xiao, additional, Pujol, Ramon M., additional, Tensen, Cornelis P., additional, Vermeer, Maarten H., additional, Whittaker, Sean, additional, Tatonetti, Nicholas P., additional, Chase, Herbert S., additional, Pe’er, Itsik, additional, and Geskin, Larisa J., additional

Published
2023
Full Text
View/download PDF

42. Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas

Author

Daniels, Jay, Doukas, Peter G., Escala, Maria E. Martinez, Ringbloom, Kimberly G., Shih, David J. H., Yang, Jingyi, Tegtmeyer, Kyle, Park, Joonhee, Thomas, Jane J., Selli, Mehmet E., Altunbulakli, Can, Gowthaman, Ragul, Mo, Samuel H., Jothishankar, Balaji, Pease, David R., Pro, Barbara, Abdulla, Farah R., Shea, Christopher, Sahni, Nidhi, Gru, Alejandro A., Pierce, Brian G., Louissaint, Jr, Abner, Guitart, Joan, and Choi, Jaehyuk

Published
2020
Full Text
View/download PDF

46. Identifying and addressing unmet clinical needs in primary cutaneous B‐cell lymphoma: A consensus‐based paper from an ad‐hoc international panel

Author

Quaglino, Pietro, primary, Pimpinelli, Nicola, additional, Zinzani, Pier Luigi, additional, Paulli, Marco, additional, Pileri, Stefano, additional, Berti, Emilio, additional, Cerroni, Lorenzo, additional, Guitart, Joan, additional, Kim, Youn H., additional, Rupoli, Serena, additional, Santucci, Marco, additional, Simontacchi, Gabriele, additional, Vermeer, Maarten, additional, Hoppe, Richard, additional, Pro, Barbara, additional, Swerdlow, Steven H., additional, and Barosi, Giovanni, additional

Published
2023
Full Text
View/download PDF

47. Low prevalence found in HCV micro-elimination program among HIV-negative MSM and TW in a community center in Spain

Author

Calaf, Àngel Rivero, primary, Tejera, Felix Pérez, additional, Dalmau-Bueno, Albet, additional, Verd, Pep Coll, additional, Cabrera Guarin, Jose Miguel, additional, Lucejko, Mariusz, additional, Guitart, Joan Reguant, additional, Pérez, Javier Fernandez, additional, Torres, Jorge Calderon, additional, Rodriguez, Jaime Romero, additional, Caballero, Federico, additional, Marazzi, Giovanni, additional, Oro, Carlos, additional, Jacobs, Daniel, additional, Vicioso, Horacio, additional, Enrique, Lisandro Moises, additional, Gonzalez, Hector Taboada, additional, Berges, Jorge Saz, additional, Roca, Ferran Pujol, additional, Meulbroek, Michael, additional, and Deirós, Roger Paredes, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results